Profil
Isabelle Dussault worked as the Global Head-Clinical Biomarker Strategy at EMD Serono, Inc. She then worked as the Senior Vice President-Research at Fusion Pharmaceuticals, Inc. for a year.
Dr. Dussault received her undergraduate and doctorate degrees from McGill University.
Anciens postes connus de Isabelle Dussault
Sociétés | Poste | Fin |
---|---|---|
FUSN PHAR | Corporate Officer/Principal | 01/04/2022 |
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Corporate Officer/Principal | - |
Formation de Isabelle Dussault
McGill University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
FUSN PHAR | Health Technology |
Entreprise privées | 1 |
---|---|
EMD Serono, Inc.
EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Health Technology |